In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 2833-2842

  Hsieh, Wan Ju ^a   Liang, Chan Jung ^a   Chieh, Jen Jie ^c   Wang, Shu Huei ^a   Lai, I Rue ^a   Chen, Jyh Horng ^b   Chang, Fu Hsiung ^b   Tseng, Wei Kung ^c,d,e   Yang, Shieh Yueh ^c   Wu, Chau Chung ^f   Chen, Yuh Lien ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^d E DA HOSPITAL   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Colon tumor; Magnetic resonance imaging; Nanoparticles; Transmission electron microscopy; Vascular endothelial growth factor

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; DEXTRAN; FERRIC FERROCYANIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODY IRON OXIDE NANOPARTICLE CONJUGATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; DISEASE MARKER; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIAL COATING; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REACTION TIME; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DEXTRANS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTOXINS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; SPLEEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84870336445     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32154     Document Type: Article

References (32)

1. Garcia M, Jemal A, Ward EM, et al. Global Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society; 2007:1-50.
2. Jemal A, Siegel R, Ward E, etal. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
3. Wang X, Feng Y, Ke T, Schabel M, Lu ZR. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent. Pharm Res. 2005;22(4):596-602.
4. Peng XH, Qian X, Mao H, etal. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine. 2008;3(3):311-321.
5. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55(18):3964-3968.
6. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581-611.
7. Yamazaki Y, Nakano Y, Imamura T, Morita T. Augmentation of vascular permeability of VEGF is enhanced by KDR-binding proteins. Biochem Biophys Res Commun. 2007;355(3):693-699.
8. Volm M, Koomägi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1in squamous cell lung cancer. Int J Cancer. 1997;74(1):64-68.
9. Brown LF, Berse B, Jackman RW, etal. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 1993;53(19):4727-4735.
10. Brown LF, Berse B, Jackman RW, etal. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol. 1995;26(1):86-91.
11. Suzuki K, Hayashi N, Miyamoto Y, etal. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res. 1996;56(13):3004-3009.
12. Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Vascular endothelial growth factor in colorectal cancer. Int J Colorectal Dis. 2004;19(6):510-517.
13. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23(5):1011-1027.
14. Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L. Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer. Mol Aspects Med. 2011;32(2):88-111.
15. Koyama T, Shimura M, Minemoto Y, etal. Evaluation of selective tumor detection by clinical magnetic resonance imaging using antibody-conjugated superparamagnetic iron oxide. J Control Release. 2012;159(3):413-418.
16. Huang KW, Yang SY, Yu CY, etal. Exploration of the relationship between the tumor burden and the concentration of vascular endothelial growth factor in liver-cancer-bearing animals using immunomagnetic reduction assay. J Biomed Nanotechnol. 2011;7(4):535-541.
17. Enochs WS, Harsh G, Hochberg F, Weissleder R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Reson Imaging. 1999;9(2):228-232.
18. Thorek DL, Chen AK, Czupryna J, Tsourkas A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng. 2006;34(1):23-38.
19. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol. 2002;135(1):37-47.
20. Towner RA, Smith N, Asano Y, etal. Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering. Tissue Eng Part A. 2010;16(2):357-364.
21. Köhne CH, Lenz HJ. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer. Oncologist. 2009;14(5):478-488.
22. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP. Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol. 1997;34(1):37-59.
23. Grothey A, Galanis E. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol. 2009;6(9):507-518.
24. Sugahara KN, Teesalu T, Karmali PP, etal. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell. 2009;16(6):510-520.
25. Yang L, Mao H, Wang YA, etal. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small. 2009;5(2):235-243.
26. Cai W, Shin DW, Chen K, etal. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 2006;6(4):669-676.
27. Lee JH, Huh YM, Jun YW, etal. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 2007;13(1):95-99.
28. Nasongkla N, Bey E, Ren J, etal. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006;6(11):2427-2430.
29. Jiang WQ, Yang HC, Yang SY, etal. Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible. J Magn Magn Mater. 2004;283(2-3):210-214.
30. Almeida JP, Chen AL, Foster A, etal. In vivo biodistribution of nanoparticles. Nanomedicine (Lond). 2011;6(5):815-835.
31. Fukumura D, Xavier R, Sugiura T, etal. Tumor induction of VEGF promoter activity in stromal cells. Cell. 1998;94(6):715-725.
32. Malvindi MA, Greco A, Conversano F, etal. Magnetic/silica nanocomposites as dual-mode contrast agents for combined magnetic resonance imaging and ultrasonography. Adv Funct Mater. 2011;21(13): 2548-2555.